person · Reporting owner

PATIENCE JOHN

Disclosed activity across 3 companies

Tapewire entity: 33236
SEC CIK: 0001021413

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Accelerate Diagnostics, IncAXDX · Entity 78156	Director	December 03, 2024	December 03, 2024
BIODESIX INCBDSX · Entity 6053	Director · Chairman	September 30, 2026	October 03, 2026
STERICYCLE INCSRCL · Entity 80873	Director	May 23, 2018	May 25, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Accelerate Diagnostics, Inc

Report date December 03, 2024 · Filed December 03, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy John Patience Living Trust dated 7/23/1993	653,224	Reported balance After 2024-12-03 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2024-12-03 · Purchase · Acquired 200,000 · Balance 653,224 F1: Represents shares purchased by the reporting person from Jack Schuler, a member of the issuer's board of directors, in a private transaction. F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.
Common StockSEC Table I · non-derivative	IndirectBy IRA	3,941	Reported balance Holding disclosure · report date 2024-12-03 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 3,941
Common StockSEC Table I · non-derivative	IndirectBy Patience Enterprises LP	214,046	Reported balance Holding disclosure · report date 2024-12-03 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 214,046 F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares purchased by the reporting person from Jack Schuler, a member of the issuer's board of directors, in a private transaction.

F2: The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.

F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

BIODESIX INC

Report date September 30, 2026 · Filed October 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	26,743	Reported balance After 2026-09-30 transaction · row 1 1 source row Row 1 · 2026-09-30 · Exercise / conversion · Acquired 1,360 · Balance 26,743 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	1,361	Reported balance After 2026-09-30 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-09-30 · Exercise / conversion · Disposed 1,360 · Balance 1,361 F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock"). F4: These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Common StockSEC Table I · non-derivative	IndirectBy Patience Enterprises LP	107,664	Reported balance Holding disclosure · report date 2026-09-30 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 107,664 F2: The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.
Common StockSEC Table I · non-derivative	IndirectBy John Patience Living Trust dated 7/23/1993	241,480	Reported balance Holding disclosure · report date 2026-09-30 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 241,480 F3: The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).
Common StockSEC Table I · non-derivative	IndirectBy Spouse	2,649	Reported balance Holding disclosure · report date 2026-09-30 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 2,649

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock ("Common Stock").

F2: The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.

F3: The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).

F4: These RSUs vest in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.

STERICYCLE INC

Report date May 23, 2018 · Filed May 25, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	3,878	Reported balance After 2018-05-23 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2018-05-23 · Grant · Acquired 1,970 · Balance 3,878 F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

Filing footnotes · ownership attribution and instrument terms

F1: In accordance with the Stericycle, Inc. Directors Deferred Stock Plan, the reporting person has elected to defer actual receipt of the shares to which such person would otherwise be entitled upon vesting until such person's separation of service from the issuer.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 01, 2016 Filed Dec 7, 2016 20:55 UTC	Accelerate Diagnostics, Inc AXDX · Entity 78156	Exercise / conversionCommon Stock	20,000	$6.48	$129,600.00	Disclosure SEC source: 0001144204-16-138466 · v454647_4.xml · nonDerivative · entry 1 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.